Message from the CEO

We are just back from MTPConnect’s North America medtech mission, with a standout group of Australian medtech start-ups, SMEs and organisations joining us in Minneapolis-St Paul and then in Toronto for a busy visit and networking program, along with a prominent Team Australia pavilion at The Medtech Conference.

We renewed our Memorandum of Understanding with influential Medical Alley headquartered in Minnesota while we were at The Medtech Conference. In discussions with Medical Alley President and CEO, Roberta Dressen, we agreed to continue working together on activities like providing introductions and in-market support, exchanging information on key issues and trends and supporting inbound and outbound missions. It’s a great connection for Australian SMEs in one of the world’s biggest medtech hubs.

Spending time with our medtech innovators it is clear how beneficial it can be to open doors to new market, commercial, investment and collaboration opportunities in North America. Forging new links at the Mayo Clinic, the University of Minnesota and beyond can really catapult a start-up’s development. Tune in to episode 183 of the MTPConnect Podcast to hear more from some of the delegates in our Medtech Matters special.

We wrapped up the mission visiting strategic partners in Washington DC – healthcare incubator @JLABS @ Washington, DC, the Australian Embassy and CSIRO, the Biomedical Advanced Research and Development Authority (BARDA) and the Administration for Strategic Preparedness and Response (ASPR).  

MTPConnect is also a long-standing supporter of ANDHealth's delegation to HLTH in Las Vegas US, an innovative conference held in October that provides digital health innovators an opportunity to gain insights on navigating the US market and international expansion. Dr Tracey Wilkinson, our Director Stakeholder Engagement WA at the WA Life Sciences Innovation Hub, joined the delegation to showcase WA’s digital health innovations.

Our international relationships are important, and through our MoU with the Korea Health Industry Development Institute (KHIDI), this week we welcomed a Korean biotech delegation to Melbourne and Sydney, hosting site visits and networking functions to help build more connections and drive collaboration between our two countries. We were honoured to spend time with KHIDI’s President Dr Cha, Soon-Do during this trip.

And yesterday, I was delighted to join AusBiotech’s CEO Rebekah Cassidy on stage at the AusBiotech 2024 conference in Melbourne to highlight why we are working together to deliver Australia’s first National Biotech and Medtech Development and Commercialisation Summit, to be held in Canberra on 19 November 2024. It's all about supercharging the 'D' in R&D! Medical science has been deemed a priority sector for the Australian economy, but that standing is not a given, so to ensure we keep it that way, it's important we come together to create a united voice for our sector – and that’s the focus of next month’s Summit.

In partnership with the Advanced Robotics for Manufacturing (ARM) Hub, we have just announced the three companies who have been selected to take part in the Biomedical AI Sprints Accelerator (BASA) – Cortical Dynamics, Microbio, and Resonait Medical Technologies!

In more good news this week, we are delighted to be partnering with the Victorian Chapter of the Association of Australian Medical Research Institutes (AAMRI VIC) and Swinburne University of Technology to deliver a new commercialisation training program for Victorian medical researchers.

The Victorian Minister for Jobs and Industry, the Hon. Natalie Hutchins MP, announced funding for the training under the Victorian Government’s Skills Solutions Partnerships program at a launch event at the WEHI.

During the month, the MTPConnect team have been leading and participating in a huge number of activities including the SABRE Futures Summit 2024 in Adelaide, a WA MTP Sector Spotlight featuring Agili8 in Perth, the NSW Drug Discovery Forum in Sydney and the Bridge Program Symposium in Melbourne.

Our Clinical Translation and Commercialisation Medtech Symposium was recently held in Sydney where we welcomed local innovators for two days of commercialisation skill building through a series of workshops with sector experts.

The next cohort of health professionals in NSW and Victoria have been selected to take part in the next Australian Clinical Entrepreneur Program, which kicks off in mid-November for a 12-month innovation program. We are delivering this initiative with the Australian Society for Medical Entrepreneurs and NSW Health.

And finally, Expressions of Interest for funding under our Targeted Translation Research Accelerator (TTRA) Drugs and Devices program close on Monday, 4 November 2024 at 4pm (AEDT). It is open to Australian spin-outs, start-ups and SMEs keen to commercialise innovative medical products to reduce the burden of cardiovascular disease and the complications of diabetes (type 1 and type 2).

As ever, an extremely busy and productive period and I really need to thank the amazing team at MTPConnect for everything they do to support the growth of Australia’s life sciences sector!

With so much happening in the sector over the next few months, we hope you continue to enjoy our newsletter and stay connected to opportunities, events and news.

Kind regards,

Stuart Dignam
Chief Executive Officer 

MTPConnect & Industry News

Team Australia Wraps Up the Medtech Conference 2024 in Toronto
 Team Australia has just wrapped up a successful medtech delegation to North America. The tour kicked off by connecting with Minnesota’s medtech sector and a visit to the Mayo Clinic precinct. Then once we hit Toronto, we hosted a high profile networking reception with MTPConnect Chair Hon. Jaala Pulford to connect dignitaries and business leaders with Australian medtech innovators. Our medtech delegation of 18 companies was in full swing joining thousands of delegates from 45 countries at The Medtech Conference. Our eye-catching Australian Pavilion welcomed visitors and during the conference, we signed an MoU with the influential Medical Alley and then wrapped up with a stopover in Washington DC with visits to JLABS and the Australian Embassy. Hear more about it all in the latest episode of the MTPConnect Podcast featuring Destination Medical Center, Medical Alley, iYarn, University of Melbourne, Materia Health and Global Victoria. 

TTRA $28.5M Accelerator Calls for EOIs to Support Heart Disease and Diabetes Innovations
 An initiative of the Medical Research Future Fund, the TTRA Drugs and Devices program can provide up to $1.5 million to help eligible Australian start-ups, spin-outs and SMEs develop innovative preventative, diagnostic, therapeutic and/or disease management drugs and devices for cardiovascular disease and the complications of diabetes (type 1 and type 2). Applications are closing 4 November 2024. Watch the information session or listen to the podcast episode to find out more about eligibility and the application process. Visit the website to submit your application.

MTPConnect Joins New Alliance to Drive Increased Procurement of Homegrown Medical Products
MTPConnect has joined a new alliance – the Australian Medtech Manufacturing Alliance (AMMA) – to grow opportunities for medtech manufacturers to sell to health services. The new initiative is forming to create a connected program, led in Victoria and building on the work of the Victorian Government’s Australian Medtech Manufacturing Centre (AMMC). Joining MTPConnect in the Alliance are BioMelbourne Network, AusBiotech, Australian Manufacturing Technology Institute Limited (AMTIL) and the Industry Capability Network Victoria, with seed funding from the Victorian Government.

New AUSCEP Cohort Announced!
The Australian Clinical Entrepreneur Program (AUSCEP) is launching its third cohort after selecting 36 participants for the 12-month innovation program run in partnership by MTPConnect and the Australian Society for Medical Entrepreneurship & Innovation (ASME). Welcome events in Sydney and Melbourne will be held on the evening of the 13 November with the first in-person Pitstop event kicking off for the group on 14 November 2024. AUSCEP is supported by LaunchVic and the NSW Agency for Clinical Innovation. For more information email the AUSCEP Team

Lions Outback Vision Project Wins $5M Pilbara healthcare initiative ‘The Challenge’ in WA
Launched in November 2022, the Government of Western Australia issued a global challenge for a world-leading innovative digital solution to resolve a pressing problem of health service delivery in the remote Pilbara region in the north of Western Australia. We have been supporting the initiative through the WA Life Sciences Innovation Hub, and travelled to Karratha for the announcement joining the finalists and members of WA's health and medical research and innovation sector along with industry supporters Rio Tinto, BHP and others. 
Read on to find out more about the winning project, and the other eight innovative projects that made it through as finalists in this unique innovation competition! 

Innovative Medtech Companies Selected to Join New AI Accelerator
We are excited to announce that three companies have been selected for the Biomedical AI Sprints Accelerator (BASA) run by ARM Hub (Advanced Robotics for Manufacturing) and MTPConnect. Congratulations to Cortical Dynamics, Microbio, and Resonait Medical Technologies!

AAMRNet Joins Global AMR Community to Highlight Action
Our  Co-chair of Australian Antimicrobial Resistance Network and MTPConnect’s Director Stakeholder Engagement Queensland recently attended AMR World Congress which kicked off in Philadelphia, USA. The Congress bought together many of the leading AMR stakeholders from across the globe to meet, brainstorm ideas and discuss ways to increase the global response to, and effectively tackle AMR. Andrew then headed to New York City for the United Nations General Assembly (UNGA) featuring the eagerly anticipated High-Level Meeting on AMR on 26 September. Check out his blogs where he shares his insights, including the path forward for AMR.

AusBiotech and MTPConnect partner to deliver Australian first National Summit
AusBiotech and MTPConnect have announced a new partnership to deliver Australia’s first National Biotech and Medtech Development and Commercialisation Summit, to be held in Canberra on 19 November 2024. The one-day Summit is set to help future-proof the country’s access to biotech and medtech innovation. 

MTPConnect Hosts Korean Biotech Delegation
MTPConnect was delighted to host a delegation of Korean health officials in Australia for AusBiotech 2024, with meetings and networking events held in both Sydney and Melbourne.
Korea is an increasingly important market and hub for the life sciences sector in Australia. As our third largest two-way trading partner, making connections with Korea is all about opening up opportunities.  

New Training to Upskill Next Generation of Victorian Medical Researchers
Victoria’s next generation of medical and medtech researchers will be upskilled in research commercialisation and connect directly with industry thanks to a real-world, collaborative training program led by the Victorian Chapter of the Association of Australian Medical Research Institutes (AAMRI VIC) in partnership with MTPConnect and Swinburne University of Technology. Victorian Minister for Jobs and Industry, the Hon. Natalie Hutchins MP, announced funding for the training under the Victorian Government’s Skills Solutions Partnerships program. 

Podcast Episodes This Month! 
We kicked off October with a podcast episode featuring TTRA's Information Session: Funding call for Drugs and Devices Addressing Cardiovascular Disease and Complications of Diabetes. Hear from our TTRA Team Lauren Kelly, Dr Mana Liao and Dr Erin McAllum as well as experts Kenny Lean from Roche Diagnostics Australia, Dr Perdita Cheshire from CSL and Renza Scibilia from Breakthrough T1D about the Drugs and Devices funding call - closing on 4 November. In the latest episode, tune in to hear our CEO Stuart Dignam chat to Australian medtech innovators at The 2024 MedTech Conference in Toronto.  

Digital Health Innovations Showcased at HLTH 2024 Australian Delegation
Dr Tracey Wilkinson, MTPConnect Director Stakeholder Engagement WA at the WA Life Sciences Innovation Hub, joined ANDHealth's Australian delegation on behalf of the WA sector to attend HLTH 2024 in Las Vegas US. MTPConnect is a long-standing supporter of ANDHealth's delegation that supports  digital health innovators seeking to navigating the US market 

MTPConnect’s Development Workshop Series Kicked Off In Sydney
The Development Workshop Series was an opportunity for start-ups participating in our Accelerator programs to get 'investor ready'. With 84 guests representing 52 organisations from around Australia attending this two-day event, this was the first event that brought together awardees of MTPConnect’s Clinical Translation and Commercialisation Medtech program (CTCM) and Targeted Translation and Research Accelerator (TTRA) program, as well as participants of the Industry Growth Program (IGP). The Finding Your Intrinsic Value workshop focused on how to identify and maximise intangible assets. CTCM medtech awardees tapped in to commercialisation expertise with a fascinating keynote from Nanosonics CEO and President, Michael Kavanagh who took us on the company’s journey of optimal product adoption.

APPLAUSE24! Nab your ticket!
The Adelaide Intermediary Program's annual and much-anticipated celebration of the South Australia's achievements in the SA medtech and healthtech sector will get underway 14 November 2024 at 5.30 pm at the SkyCity Ballroom, Adelaide. Presented by MTPConnect, the Government of South Australia, and sponsored by FB Rice in partnership with AusBiotech, this is an opportunity for all across SA's ecosystem to come together and celebrate with a round of APPLAUSE. Register!

Connect with the Adelaide Intermediary Program's Fee-Free Services
Do you need to elevate your research impact, build connections and access advice to identify funding opportunities? MTPConnect's Adelaide Intermediary Program team will be working from the Tonsley Innovation District on the first Thursday of each month for drop-ins or one-on-one consultations. Access the fee-free services of the program now and book a meeting.

Mark your Calendars for WA Life Sciences & Innovation Hub's Spotlight 2024

Brought to you by the WA Life Sciences Innovation Hub, Life Sciences WA and AusBiotech, the Spotlight on 2024 will be a celebration of Western Australia’s dynamic life sciences sector. This event is a capstone on the Hub’s successful Spotlight Series, a monthly event series where the medical life sciences sector gathers to connect, collaborate, and learn from the stories and successes of organisations and leaders developing health and medical innovations. Join the waitlist if you would like to attend. 

Sector Snapshot

• Congratulations to Australia's medical innovators with $55 million awarded to 23 successful CRC-P projects! See the full list here! And a shout out to 4D Medical, ZiP Diagnostics, Neo Bionica with Kali Healthcare to name a few...

• Omico welcomes unique multi-year collaboration with Tessellate BIO and Children’s Medical Research Institute on ‘ALT+’ cancers

• Congratulations to the latest successful 2024 recipients of the WA Innovation Booster Grant (IBG). The IBG is designed to assist innovators overcome some of the barriers along the way to commercialisation, as well as build new relationships between innovators, consultants and service providers. 

• At the recent Western Australian Future Health & Research Fund's open day in Albany, the WA government launched a further seven funding programs for researchers working in health and medical research

• Recce Pharmaceuticals has successfully dosed half of the targeted 30 patients in its Phase 2 trial for Acute Bacterial Skin and Skin Structure Infections

• SpeeDx appoints a new CEO to drive global expansion

• The Australian Government released the 2024 National Defence Strategy, outlining a 10-year vision for an integrated, secure approach to innovation, science and technology capability development and translation

• Five Australian health science startups - Eugene, Atmo Biosciences, Immunosis, Metabolic Health Solutions and Humanetix - will share in $3.25 million in additional funding from the MRFF as part of stage two of a program being managed by ANDHealth

• Needle free biotechnology company Vaxxas licenses RSV vaccine candidate

• LBT Innovations announced Bristol Myers Squibb completed the purchase of its APAS Independence. This is the first sale of their APAS Independence to a customer in the United States

• Avance Clinical won the South Australian Premier’s Business & Export Awards for the International Health category. This is their fifth win!

•  Monash University Clinical Trials Centre (MUCTC) launches a game-changing consumer and community engagement platform open to all researchers from universities and companies across Australia who wish to engage consumers and community members in their research.

• CSL was recognised as 'Manufacturer of the Year - Large Business', and 'Leader in Health Technologies' at the Victorian Manufacturing Hall of Fame Awards 2024, an initiative of Business Victoria

• Watch the news on BiVACOR , a company supported by our TTRA program. Their titanium heart has kept a man alive while waiting for a heart transplant, and the company was recently named in TIME’s 2024 Best Inventions under the Experimental category

• Construction has kicked off on a world-leading RNA research and pilot manufacturing facility at Macquarie University

• Vicebio, developing next-generation vaccines for respiratory viruses utilising its proprietary Molecular Clamp technology, discovered at The University of Queensland, has announced a $100 million Series B financing and initiation of phase 1 clinical study of RSV/hMPV bivalent vaccine

• Checkout out CSIRO's new online resource to increase antimicrobial resistance knowledge - 'AMR Action and Insights' - an initiative of CSIRO Minimising Antimicrobial Resistance Mission, which is supported by the Australian Antimicrobial Resistance Network (AAMRNet), established and operated by MTPConnect.

• Find out how Australia is ready to play a leading role in the rise of the global radiopharmaceutical industry with MTPConnect's discussion paper, 'From Mines to Medicines. Australia’s Radiopharmaceuticals Future', outlining a national roadmap to maximise this opportunity

• Read MTPConnect's latest snapshot report on Australia’s Clinical Trials Sector released in June 2024
• The results are in - read MTPConnect's TTRA impact report,  ‘Transforming health outcomes for diabetes and cardiovascular disease in Australia – Interim report on impacts of the first Targeted Translation Research Accelerator’
• Read the latest report from MTPConnect and its Australian Antimicrobial Resistance Network (AAMRNet): Fighting superbugs: Ensuring Australia is ready to combat the rise of drug resistant infections developed by Evohealth
• Read the National Action Plan to Build Australia’s Diagnostic Technology Sector 

• gemaker's website is a great resource for the innovation and commercialisation sector. And subscribe to gemaker's Monthly Insights newsletter for researchers, inventors and innovative businesses

• Join the mailing list of the new Victorian Medtech Skills and Device Hub, bringing together local businesses, universities and education providers to accelerate Victoria's medtech sector and deliver the workforce of the future

Sector Opportunities 

• The University of Melbourne convened a panel of experts with experience of the MedTech commercialisation process in the webinar, 'MedTech commercialisation: Insights for translating research'. Topics included why commercialisation is important, the three most important factors in translating MedTech research, and when to spinout a company. Watch the webinar!
• Expressions of interest for the second round of CUREator+ are now open! Delivered in partnership by Brandon BioCatalyst and ANDHealth, CUREator+ supports the translation and commercial development of promising biomedical and digital health technologies. EOIs close 4 December 2024
• Applications are open for Orbit, a 12-month accelerator designed to support early-stage start-ups through the ‘valley of death’ stage and onto scalability and growth, delivered by Bloom,  a WA based youth-led innovation hub
• Start-ups and entrepreneurs in the Northern Territory - apply now for the Business Innovation Program and receive up to $30,000 in government grant funding, $2,000 in advisory services from a pre-approved advisor, and $10,000 for expenses incurred in commercialising your innovation. Applications close 30 June 2025
• Nominations open for the 2025 Prime Minister’s Prizes for Science! Nominate someone you know for the 2025 prizes by 17 December 2024
• The Industry Capability Network - Victoria is launching an update to the Victorian Medtech Manufacturing Capability Directory to provide greater coverage of the medtech supply chain in the state

• Are you working on groundbreaking diagnostics or medical device countermeasures that address public health? I-CREATE is part of a global network of accelerator hubs that provide product development funding, accelerator services, and access to expertise for innovators developing health security solutions. Start-ups and university-backed projects worldwide can apply for non-dilutive funding ranging from $50K to $200K. This funding supports the development, evaluation, or validation of innovative solutions aligned with BARDA’s mission to enhance pandemic preparedness and health security. Apply for the next cohort in 2025

• Nominations are open for BioMelbourne Network's 2025 Women in Leadership Awards. Submit by 20 November 2024
• The Industry Growth Program provides support for innovative SMEs to commercialise and grow their business within the National Reconstruction Fund priority areas, such as medical science. Get connected to an Industry Growth Program adviser who will provide tailored advice to support your commercialisation and/or growth project. And you may be eligible to apply for further funding
• FundWA Open Door initiative provides local founders with the opportunity to discuss fundraising, or pitch to a member of our team. No warm introduction needed, just apply
• Cicada HealthTech Hub Ask an Expert is an exciting opportunity for clinicians, researchers, and health tech founders to gain insights and personalised advice from a distinguished panel of Mentors, Investors, and Funders. Visit the website to book an appointment for a 20-minute session online or at Westmead Innovation Centre
• The NSW government and Cicada Innovations are providing nationwide access to free online commercialisation training, 'NSW Deep Tech Commercialisation Program: Foundations
• Invest NSW's MVP (Minimum Viable Product) Ventures 2024-2025 supports start-ups and innovative SMEs in the product lifecycle between early-stage research and mature investment opportunities, through grants to drive the commercialisation of highly innovative and new products. Closes 28 February 2025
• Applications are open for X-TEND WA, a competitive co-investment grants program, investing in organisations that deliver initiatives to assist and support the WA Innovation Ecosystem provided by WA's Department of Jobs, Tourism, Science and Innovation

• WA's Health and medical life sciences industry: Market Access Grant Scheme 2024 supports Western Australian health and medical life sciences companies in advancing their business development through national and international conferences and events in 2024. Funding support is 80% of eligible costs (excluding GST) and up to a maximum of $5,000 per company. Closes when all funds are expended

• CSIRO Kick-Start is a year-round initiative providing matched funding support for innovative Australian start-ups and small businesses, with access to CSIRO’s research expertise and capabilities to help grow and develop their business
• The Seed-Start program (South Australia) supports commercialisation of innovative, early-stage SA startups. Applications are ongoing
• Check out the APR.Intern internships available in the medtech and pharma sector!
• Are you a biotech innovator looking for specialised facilities? Jumar Bioincubator, Australia's newest biotech incubator is offering affordable lab and office space, along with practical support, to nurture young biotech ventures. Find out more

• ATSE's IMNIS Ignite is a postgraduate internship program connecting industry-ready IMNIS Engage alumni with industry-based internships at host organisations. Register your interest.

• Keep up with funding opportunities and subscribe to the monthly MRFF newsletter, from the Australian Government Department of Health and Aged Care

• Do you have a great idea for a medical or assistive device and need R&D assistance? Connect with MDPP 

Events​

• 6 November 2024 - Non-Dilutive Investment to Boost Digital Health Commercialisation, Cicada Health Tech Hub x ANDHealth (Westmead, NSW)
• 7 November 2024 - Promoting success: telling your story with impact, Cooperative Research Australia (online)
• 11-25 November 2024 - National Innovation Policy Forum, Cooperative Research Australia (Melbourne & Sydney)
• 12 November 2024 - 2025 Women in Leadership Awards celebration, BioMelbourne Network (Melbourne)
• 13-14 November 2024 - ACADI Partnering Summit (Melbourne)
• 14 November 2024 - APPLAUSE24, Adelaide Intermediary Program (Adelaide)
• 14 November 2024 - CHICC Expert Workshop: Achieving Impact with Digital Health Pilots, ANDHealth (Melbourne)
• 18 November 2024 - AAMRNet 'World Antimicrobial Awareness Week' Workshop (Canberra)
• 19 November 2024 - Women in MedTech Networking Event - Mentoring Program, MTAA (Sydney)
• 19 November 2024 - National Biotech and Medtech Development and Commercialisation Summit, AusBiotech & MTPConnect (Canberra)
• 21 November 2024 - 2024 BioMelbourne Network Annual General Meeting & Networking Event (Melbourne)
• 26 November 2024 - Spotlight on 2024, WA Life Sciences & Innovation Hub (Perth)
• 26 November 2024 - BioForum – Biotech scandal to SaaS Success: Fireside chat with Theranos ’survivor’ Marissa Senzaki, MDMD (Melbourne)
• 27 November 2024 - Scaling healthtech with sustainable strategies, MDMD (Melbourne)
• 28 November 2024 - Practical co-design for everyone: the secret to success, Cooperative Research Australia (online)
• 28 November 2024 - BioForum – BioNTech: From concept to clinical trials, BioMelbourne Network (Melbourne)
• 2-6 December 2024 -  Global Tech and Innovation Program 2024 (WA)
• 2-6 December 2024 - West Tech Fest 2024 (WA)
• 5 December 2024 - ACTIVATE 2024 Showcase, ANDHealth (Melbourne)
• 10 December 2024 - ANDHealth Summit - From New Frontiers to the Frontline (Melbourne)
• 11 December 2024 - BioMelbourne Network, AusBiotech and ARCS VIC End-of-Year Function 2024 – save the date (Melbourne)
• 12-13 February 2025 - Science Meets Parliament 2025, Science & Technology Australia (Canberra)
• 25 - 27 February 2025 - Global Life Science Partnering & Investor Conference, BioCom California (La Jolla, California US)
• 18 - 19 March 2025 - Life Sciences Summit, Biotech NZ & NZTech (Wellington, New Zealand)
• 16 May 2025 - Connecting Women Lunch, BioMelbourne Network (Melbourne)

To see what industry events are coming up in 2024, visit our events page.

Case Study Showcase | RNA Expert Works With SpeeDx to Develop New Diagnostic for STIs That Could Help Fight Antibiotic Resistance

Current molecular diagnostics tests are great at identifying microbes but not so good at working out which ones are actively causing an infection, or whether they are still active. SpeeDx is working on a program that could solve this dilemma and received a REDI Fellowship to bring Associate Professor Nham Tran on board to tap into his expertise in identifying pathogens through their RNA. During the Fellowship, A/Professor Tran from University of Technology Sydney (UTS) worked on the InSignia project – a newly developed diagnostic test for sexually transmitted infections for types of chlamydia and gonorrhoea. A/Professor Tran specialises in investigation of small RNA biomarkers within clinical contexts and the exploration of the role of small RNAs in various diseases. Find out more...

Sector Profile: MetaGene

MetaGene offers validated and certified pathology, histology, and cancer diagnostic tools, in addition to microbiology hardware and tools, antibody, protein and oligo purification and manufacturing reagents and hardware for the Australian Diagnostic, Life Science research and BioProcessing/Pharmaceutical markets. Learn more in our Sector Directory.

List your organisation on the MTPConnect Sector Directory.